Get started
Author

Qiuju Xun

Discovery of JND3229 as a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy
2018 · Xiaoyun Lu, Tao Zhang, et al. · ACS Medicinal Chemistry Letters · 69
Small-Molecule CSF1R Inhibitors as Anticancer Agents
2019 · Qiuju Xun, Zhen Wang, et al. · Current Medicinal Chemistry · 39
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors
2017 · Zhen Wang, Yali Zhang, et al. · ACS Medicinal Chemistry Letters · 38
PDF
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a ]pyrazin-3-ylethynyl)-4-isopropyl- N -(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2
2018 · Zhen Wang, Yali Zhang, et al. · Journal of Medicinal Chemistry · 33
Design, Synthesis, and Structure–Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5-d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors
2018 · Qiuju Xun, Zhang Zhang, et al. · Journal of Medicinal Chemistry · 23
2-Oxo-3,4-dihydropyrimido[4,5-d] pyrimidines as new reversible inhibitors of EGFR C797S (Cys797 to Ser797) mutant
2019 · Xianglong Hu, Qiuju Xun, et al. · Chinese Chemical Letters · 19
Discovery of BW710 as a potent, selective and orally bioavailable fibroblast growth factor receptor 2 (FGFR2) inhibitor
2025 · Bowen Yang, Qiuju Xun, et al. · European Journal of Medicinal Chemistry · 9
2 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors
2026 · Pinglian Wu, Zhaodi Tian, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry
PDF
2H-pyrazolo[3,4-d]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors
2026 · Wu, Pinglian, Tian, Zhaodi, et al. · Figshare
Works count: 9
Citation count: 230
H-index: 7
I10-index: 6
Year
Topic
Type